Although it has been hypothesized that the use of valproic acid could reduce the risk of COVID-19 infection or reduce viral load by its association with angiotensin-converting enzyme 2 and transmembrane serine protease 2,32 we found a significant increase in infection and a similar (although nonsignificant) increase in mortality. This evidence concerns the gene ACE2 and infection.